Galectin Therapeutics (GALT) Other Accumulated Expenses (2011 - 2015)
Galectin Therapeutics' quarterly Other Accumulated Expenses came in at $6000.0 in Q3 2015, up 200.0% year-on-year from $2000.0 in Q3 2014, and down 14.29% quarter-over-quarter from $7000.0 in Q2 2015.
Galectin Therapeutics has reported Other Accumulated Expenses for 5 years, with the latest figure at $6000.0 in Q3 2015.
- For the quarter ending Q3 2015, Other Accumulated Expenses rose 200.0% year-over-year to $6000.0; the trailing twelve-month figure through Sep 2015 stood at $6000.0 (up 200.0% YoY), and the FY2014 full-year result was $7000.0, down 68.18% from the prior year.
- Other Accumulated Expenses for Q3 2015 stood at $6000.0, down from $7000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $98000.0 in Q1 2014, with the low at $2000.0 in Q2 2014.
- Average Other Accumulated Expenses over 5 years is $29800.0, with a median of $10000.0 recorded in 2012.
- Peak annual rise in Other Accumulated Expenses reached 790.91% in 2014, while the deepest fall reached 96.3% in 2014.
- Tracing GALT's Other Accumulated Expenses over 5 years: stood at $97000.0 in 2011, then sank by 89.69% to $10000.0 in 2012, then soared by 120.0% to $22000.0 in 2013, then slumped by 68.18% to $7000.0 in 2014, then dropped by 14.29% to $6000.0 in 2015.
- The last three Other Accumulated Expenses figures came in at $6000.0 (Q3 2015), $7000.0 (Q2 2015), and $72000.0 (Q1 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 6,000.00 |
| Jun 30, 2015 | 7,000.00 |
| Mar 31, 2015 | 72,000.00 |
| Dec 31, 2014 | 7,000.00 |
| Sep 30, 2014 | 2,000.00 |
| Jun 30, 2014 | 2,000.00 |
| Mar 31, 2014 | 98,000.00 |
| Dec 31, 2013 | 22,000.00 |
| Sep 30, 2013 | 54,000.00 |
| Jun 30, 2013 | 10,000.00 |
| Mar 31, 2013 | 11,000.00 |
| Dec 31, 2012 | 10,000.00 |
| Sep 30, 2012 | 46,000.00 |
| Jun 30, 2012 | 3,000.00 |
| Dec 31, 2011 | 97,000.00 |